Showing 3001-3010 of 5621 results for "".
- Sight Sciences to Feature Interactive Panel Discussions of Real-World Use of the Omni Surgical System as a Standalone Glaucoma Treatment at AAOhttps://modernod.com/news/sight-sciences-to-feature-interactive-panel-discussions-of-real-world-use-of-the-omni-surgical-system-as-a-standalone-glaucoma-treatment-at-aao/2481125/Sight Sciences announced that 12 ophthalmic physicians will present their first-hand experience using the Omni Surgical System as a standalone minimally invasive glaucoma surgery (MIGS) during this year’s annual AAO convention at McCormick Place in Chicago. Meeting delegates are invite
- eSight Assistive Device for Visually Impaired Available for Demonstrations at AAOhttps://modernod.com/news/esight-assistive-device-for-visually-impaired-available-for-demonstrations-at-aao/2481104/Vision enhancement platform,
- Glaukos Announces More Than 1 Million iStent Devices Implanted Worldwidehttps://modernod.com/news/glaukos-announces-more-than-1-million-istent-devices-implanted-worldwide/2481064/Glaukos announced that it has reached a milestone with its iStent family of technologies having now been implanted in more than 1 million procedures worldwide. “One million iStents implanted is a tremendous accomplishment and I’m grate
- Opus Genetics Hosts Inaugural Patient Advocacy Outreach Webinar on Inherited Retinal Diseaseshttps://modernod.com/news/opus-genetics-hosts-inaugural-patient-advocacy-outreach-webinar-on-inherited-retinal-diseases/2481058/Opus Genetics announced the release of the first patient advocacy outreach webinar featuring presentations by Opus leadership: Ben Yerxa, PhD, and CEO of Opus; Ash Jayagopal, PhD, and chief scientific officer; Joe Schachle, COO; and Jennifer Hunt, chief development officer. The recorded webinar,
- Zeiss Integrated Workflow Solutions Designed to Create Digital Transformation in Health Carehttps://modernod.com/news/zeiss-integrated-workflow-solutions-are-creating-the-digital-transformation-in-health-care/2481054/At Zeiss Innovation Week, taking place September 6-8, 2022, Zeiss Medical Technology will host experts in ophthalmology to share their personal experiences of how the power of integrated workflow solutions, data management, and a range of new software applications enable improved efficiencies and
- Sight Sciences Introduces SION—The First Bladeless Device Used in Goniotomyhttps://modernod.com/news/sight-sciences-introduces-the-sion-the-first-bladeless-device-used-in-goniotomy/2481040/Sight Sciences announced the launch of
- Show Organizers Announce Reimagined Floor Plan for Vision Expo East 2023https://modernod.com/news/show-organizers-announce-reimagined-floor-plan-for-vision-expo-east-2023/2481037/The Vision Council and RX, co-organizers of Vision Expo, shared plans for a reimagined show floor layout that will debut at Vision Expo East 2023, taking place March 16–19 at the Javits Center in New York City. The new layout will feature all of Vision Expo’s Show Fl
- Ocuphire Extends US Patent Protection for Drug Candidate Nyxol for Reversal of Mydriasis by 5 More Years Into 2039https://modernod.com/news/ocuphire-extends-us-patent-protection-for-drug-candidate-nyxol-for-reversal-of-mydriasis-by-5-more-years-into-2039/2481011/Ocuphire Pharma announced the issuance of a new U.S. Patent (No. 11,400,077), which provides added intellectual property protection for the company’s late-stage product candidate, Nyxol (phentolamine mesylate), with claims directed to methods for treating mydriasis using phentolamine m
- Verana Health Presents Geographic Atrophy and Diabetic Macular Edema Research at ASRS 2022https://modernod.com/news/verana-health-presents-geographic-atrophy-and-diabetic-macular-edema-research-at-asrs-2022/2480976/Verana Health delivered two podium presentations at the American Society of Retina Specialists annual meeting in New York City on July 15. The research findings were generated through analysis of Ophthalmology Qdata, real-world data resulting from the curation
- Frontera Therapeutics Completes $160 Million Series B Financing to Fund Clinical Development and Manufacturing Capabilitieshttps://modernod.com/news/frontera-therapeutics-completes-160-million-series-b-financing-to-fund-clinical-development-and-manufacturing-capabilities/2480975/Frontera Therapeutics announced successful completion of a $160 million Series B funding round. In addition, Frontera announced that the FDA has accepted the company’s investigational new drug (IND) application to initiate a first-in-human clinical trial of FT